Wealthcare Advisory Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-1,803
Closed -$89K – 1674
2021
Q1
$89K Buy
+1,803
New +$86.6K 0.01% 702
2020
Q2
– Sell
-309
Closed -$13K – 1192
2020
Q1
$13K Hold
309
– – ﹤0.01% 853
2019
Q4
$15K Hold
309
– – ﹤0.01% 844
2019
Q3
$14K Sell
309
-21
-6% -$906 ﹤0.01% 854
2019
Q2
$14K Buy
330
+9
+3% +$383 ﹤0.01% 826
2019
Q1
$14K Hold
321
– – ﹤0.01% 744
2018
Q4
$14K Sell
321
-772
-71% -$34K ﹤0.01% 714
2018
Q3
$49K Buy
1,093
+205
+23% +$8.76K 0.01% 476
2018
Q2
$36K Buy
888
+10
+1% +$394 0.01% 537
2018
Q1
$35K Sell
878
-950
-52% -$39.5K 0.01% 461
2017
Q4
$79K Hold
1,828
– – 0.02% 300
2017
Q3
$91K Buy
+1,828
New +$88.5K 0.03% 226

Other funds holding SNY

Wealthcare Advisory Partners's SNY Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Sanofi (SNY) in Q2 2021, closing a stake of 1,803 shares — an estimated $89K sold.

Wealthcare Advisory Partners first reported a position in SNY in Q3 2017 and held it in 12 quarters. The position peaked at $91K in Q3 2017. 586 funds tracked by Wall St. Rank hold SNY as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Sanofi position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 1,803 Sanofi shares in Q2 2021, an estimated $89K.
  • Wealthcare Advisory Partners first reported a position in Sanofi in Q3 2017 and held it in 12 quarters.
  • Wealthcare Advisory Partners's Sanofi position peaked at $91K in Q3 2017.
  • 586 funds tracked by Wall St. Rank held Sanofi as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.